157 related articles for article (PubMed ID: 2577702)
1. Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
Goldberg ME; Seltzer JL; Azad SS; Smullens SN; Marr AT; Larijani GE
J Cardiothorac Anesth; 1989 Aug; 3(4):411-7. PubMed ID: 2577702
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
3. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
[TBL] [Abstract][Full Text] [Related]
4. A comparison of esmolol and labetalol for the treatment of perioperative hypertension in geriatric ambulatory surgical patients.
Singh PP; Dimich I; Sampson I; Sonnenklar N
Can J Anaesth; 1992 Jul; 39(6):559-62. PubMed ID: 1353708
[TBL] [Abstract][Full Text] [Related]
5. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
Hauger-Klevene JH
Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
[TBL] [Abstract][Full Text] [Related]
7. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.
Huey J; Thomas JP; Hendricks DR; Wehmeyer AE; Johns LJ; MacCosbe PE
Am J Hypertens; 1988 Jul; 1(3 Pt 3):284S-289S. PubMed ID: 3415804
[TBL] [Abstract][Full Text] [Related]
9. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
[TBL] [Abstract][Full Text] [Related]
10. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
[No Abstract] [Full Text] [Related]
11. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
Vermillion ST; Scardo JA; Newman RB; Chauhan SP
Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
[TBL] [Abstract][Full Text] [Related]
14. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
Lijnen PJ; Amery AK; Fagard RH; Reybrouck TM; Moerman EJ; De Schaepdryver AF
J Cardiovasc Pharmacol; 1979; 1(6):625-32. PubMed ID: 94628
[TBL] [Abstract][Full Text] [Related]
15. A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery.
Kross RA; Ferri E; Leung D; Pratila M; Broad C; Veronesi M; Melendez JA
Anesth Analg; 2000 Oct; 91(4):904-9. PubMed ID: 11004045
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of labetalol on blood pressure in relation to the sympathetic nervous system and plasma renin activity.
Vlachakis ND; Barr J; Velasquez M; Alexander N; Maronde R
Clin Pharmacol Ther; 1984 Jun; 35(6):782-7. PubMed ID: 6375933
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
[TBL] [Abstract][Full Text] [Related]
18. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
Weber MA; Drayer JI; Kaufman CA
J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
[TBL] [Abstract][Full Text] [Related]
19. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
Hecht JP; Richards PG
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
[TBL] [Abstract][Full Text] [Related]
20. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
